<DOC>
	<DOCNO>NCT01707758</DOCNO>
	<brief_summary>The primary objective develop rapid vitro screen assay detection pancreatic cancer biomarkers blood patient pancreatic cancer .</brief_summary>
	<brief_title>Detection Cancer-Specific Active Proteases Blood Via Fluorescence</brief_title>
	<detailed_description>The goal project develop rapid vitro screen assay detection cancer biomarkers blood . The aim test optimization nanoparticle sensor , base cyanine dye chemically link Fe/Fe3O4 nanoparticles via protease-selective consensus ( cleavage ) sequence . The focus quantitative determination active cancer-specific protease blood via simple fluorescence measurement . The matrix metalloproteinases , urokinase-type plasminogen activator , cathepsins , up-regulated vast majority progress cancer , therefore , serve marker cell survival/tumor progression , angiogenesis , tissue remodeling/invasion</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Inclusion Criteria Pancreatic Cancer Patients : Patients either histologic diagnosis pancreatic carcinoma clinical picture consistent pancreatic cancer undergo surgery diagnostic procedure confirm diagnosis . Patients prior treatment surgery Inclusion Criteria Healthy Subjects : Subjects prior history cancer Exclusion Criteria Pancreatic Cancer Patients Any prior treatment pancreatic cancer Poorly control diabetes Exclusion Criteria Healthy Subjects Poorly control diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>pancreatic cancer</keyword>
	<keyword>nanoparticle</keyword>
	<keyword>protease</keyword>
	<keyword>cell survival</keyword>
	<keyword>tumor progression</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>tissue remodeling/invasion</keyword>
</DOC>